Table 2.
Gene | Parameter (ms) | Risk group | Non-risk group | Unadjusted p-valuea | Adjusted p-valueb |
---|---|---|---|---|---|
DRD4 | μ | 212.2 | 209.1 | 0.96 | 0.56 |
σ | 52.3 | 47.3 | 0.24 | 0.94 | |
τ | 122.7 | 83.2 | 0.013* | 0.14 | |
SCL6A3/DAT1 | μ | 214.8 | 201.8 | 0.48 | |
σ | 51.2 | 47.2 | 0.92 | ||
τ | 97.3 | 117.2 | 0.26 |
*Indicates a significance level of 0.05 or less.
aUnadjusted p-value was obtained by means of Wilcoxon sum rank test.
bPresented p-values are adjusted by age, sex, and clinical status (ADHD, healthy sibs, and/or TD children).